ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 185 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,828,937 | -9.2% | 1,838,356 | +42.3% | 0.00% | 0.0% |
Q2 2023 | $6,419,750 | -36.6% | 1,292,141 | -36.9% | 0.00% | -33.3% |
Q1 2023 | $10,123,494 | +67241.8% | 2,049,256 | -14.3% | 0.00% | -25.0% |
Q4 2022 | $15,033 | -99.9% | 2,390,104 | +37.8% | 0.00% | -42.9% |
Q3 2022 | $18,732,000 | +30.9% | 1,734,787 | +38.3% | 0.01% | +40.0% |
Q2 2022 | $14,306,000 | +94.8% | 1,254,688 | +55.7% | 0.01% | +150.0% |
Q1 2022 | $7,344,000 | -33.9% | 805,987 | +8.2% | 0.00% | -33.3% |
Q4 2021 | $11,114,000 | +26.8% | 744,728 | +118.3% | 0.00% | 0.0% |
Q3 2021 | $8,768,000 | +1438.2% | 341,155 | +1461.8% | 0.00% | – |
Q2 2021 | $570,000 | -26.1% | 21,844 | 0.0% | 0.00% | – |
Q1 2021 | $771,000 | -32.7% | 21,844 | -51.8% | 0.00% | – |
Q4 2020 | $1,145,000 | -37.5% | 45,353 | -6.6% | 0.00% | -100.0% |
Q3 2020 | $1,831,000 | +283.9% | 48,548 | +164.2% | 0.00% | – |
Q4 2019 | $477,000 | -7.6% | 18,373 | -3.0% | 0.00% | – |
Q3 2019 | $516,000 | – | 18,949 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |